WCBA
Weaver C. Barksdale & Associates’s Novartis NVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-17,340
| Closed | -$1.29M | – | 525 |
|
|
2017
Q1 | $1.29M | Buy |
17,340
+4,683
| +37% | +$348K | 1.52% | 37 |
|
|
2016
Q4 | $922K | Buy |
12,657
+4,362
| +53% | +$318K | 1.49% | 39 |
|
|
2016
Q3 | $655K | Buy |
8,295
+931
| +13% | +$73.5K | 1.1% | 55 |
|
|
2016
Q2 | $608K | Hold |
7,364
| – | – | 1.06% | 55 |
|
|
2016
Q1 | $533K | Sell |
7,364
-92
| -1% | -$6.66K | 0.4% | 85 |
|
|
2015
Q4 | $642K | Hold |
7,456
| – | – | 0.5% | 77 |
|
|
2015
Q3 | $685K | Hold |
7,456
| – | – | 0.55% | 69 |
|
|
2015
Q2 | $733K | Hold |
7,456
| – | – | 0.54% | 73 |
|
|
2015
Q1 | $735K | Sell |
7,456
-183
| -2% | -$18K | 0.55% | 69 |
|
|
2014
Q4 | $708K | Sell |
7,639
-350
| -4% | -$32.4K | 0.57% | 76 |
|
|
2014
Q3 | $752K | Hold |
7,989
| – | – | 0.62% | 57 |
|
|
2014
Q2 | $723K | Buy |
7,989
+2,800
| +54% | +$253K | 0.58% | 65 |
|
|
2014
Q1 | $441K | Sell |
5,189
-285
| -5% | -$24.2K | 0.37% | 80 |
|
|
2013
Q4 | $440K | Sell |
5,474
-133
| -2% | -$10.7K | 0.37% | 78 |
|
|
2013
Q3 | $430K | Buy |
5,607
+4,225
| +306% | +$324K | 0.39% | 68 |
|
|
2013
Q2 | $98K | Buy |
+1,382
| New | +$98K | 0.1% | 110 |
|